Father-Son Investment Group With Proven Record Of Success Relaunches Nutritional Supplement Company
June 27, 2012
Father-Son Investment Group With Proven Record Of Success Relaunches Nutritional Supplement Company
Nutrition 21, a leader in the nutritional supplement industry, today announced the official relaunch of the company. The relaunch, featuring the introduction of a new management team and a redesigned, interactive website that showcases Nutrition 21’s quality, functional ingredients, will reintroduce the company to the industry.
more news
November 27, 2018
Nutrition 21’s Muscle Protein Synthesis Boosting Ingredient Velositol® is Now Powering Up Olympus Labs’ NEW Superior Protein
Nutrition 21, LLC (“Nutrition 21”), has announced that its clinically substantiated ingredient, Velositol®, which has been shown to…
October 25, 2018
Nutrition 21, LLC Announces New Consumer Brand Awareness Data for Nitrosigine® and Velositol® and Hires Erika Harvey as West Coast Key Accounts Manager
Nutrition 21, LLC (“Nutrition 21”), is pleased to announce the results of a new brand awareness survey recently conducted by American Media…
October 9, 2018
Powders Dominate Key Sports Nutrition Categories, Featuring Nutrition21, Nitrosigine, Velostol
Natural Products Insider – In the sports nutrition market’s love affair with powders for muscle, energy and recovery products, innovation…
September 25, 2018
Nitrosigine® Is Now Powering Vapor One™️ From Muscletech™️
Nutrition 21, LLC (“Nutrition 21”), has announced that its clinically substantiated ingredient, Nitrosigine®, is now featured in Vapor…
September 18, 2018
Nitrosigine® Is Now Fueling Black Onyx Shatter Neuro N.O. From Muscletech™️
Nutrition 21, LLC (“Nutrition 21”), has announced that its clinically substantiated ingredient, Nitrosigine®, is now featured in Black Onyx…
August 23, 2018
Nitrosigine® Is Now Powering UP C4 Ultimate® Shred From Cellucor®
Nutrition 21, LLC (“Nutrition 21”), has announced that its clinically substantiated ingredient, Nitrosigine®, is now featured in…
August 17, 2018
Nutrition21, LLC Announces New Additions to Sales and Senior Leadership Teams
Nutrition 21, LLC (“Nutrition 21”) s proud to announce that William “Skip” Hammock has joined Nutrition 21 as Manager of Key Accounts and…
July 11, 2018
Nutrition21 Study Adds Evidence Supporting More Bioavailable Form Of Arginine
Results presented at Nutrition 2018 Conference, hosted by the American Society of Nutrition, shows that Inositol-stabilized arginine is…
July 10, 2018
Nutrition 21, LLC Presents New Study Linking Nitrosigine®’s Enhanced Absorption to the Inhibition of Arginase at the American Society for Nutrition’s 2018 Annual Meeting
Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of new clinical study results demonstrating that Nitrosigine®…
Nutrition21 Proudly Supports the Following Industry Associations

©2023 Nutrition21, LLC. All rights reserved.
Nitrosigine®, Velositol®, nooLVL®, Lustriva®, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,028,879; 9,119,835; 9,597,404; 9,675,702; 10,183,049; and 10,245,325.
June 27, 2012
Nutrition21 Assets Acquired By An Investment Group Led By Messrs. Philip and Michael Satow
November 28, 2011
Nutrition21 Assets Acquired By An Investment Group Led By Messrs. Philip and Michael Satow
The assets of Nutrition 21 have been acquired by an investment group led by Phillip and Michael Satow. The Company will continue to operate as Nutrition 21. Michael Satow will serve as President and Chief Executive Officer and Phillip Satow as Chairman of the Board. Phillip and Michael together have almost 50 years of healthcare experience. Most recently, they founded and built JDS Pharmaceuticals, LLC (“JDS”), a specialty pharmaceutical company focused on the psychiatric and women’s health markets. JDS was sold in 2007 to Noven for $125 million.
more news
November 27, 2018
Nutrition 21’s Muscle Protein Synthesis Boosting Ingredient Velositol® is Now Powering Up Olympus Labs’ NEW Superior Protein
Nutrition 21, LLC (“Nutrition 21”), has announced that its clinically substantiated ingredient, Velositol®, which has been shown to…
October 25, 2018
Nutrition 21, LLC Announces New Consumer Brand Awareness Data for Nitrosigine® and Velositol® and Hires Erika Harvey as West Coast Key Accounts Manager
Nutrition 21, LLC (“Nutrition 21”), is pleased to announce the results of a new brand awareness survey recently conducted by American Media…
October 9, 2018
Powders Dominate Key Sports Nutrition Categories, Featuring Nutrition21, Nitrosigine, Velostol
Natural Products Insider – In the sports nutrition market’s love affair with powders for muscle, energy and recovery products, innovation…
September 25, 2018
Nitrosigine® Is Now Powering Vapor One™️ From Muscletech™️
Nutrition 21, LLC (“Nutrition 21”), has announced that its clinically substantiated ingredient, Nitrosigine®, is now featured in Vapor…
September 18, 2018
Nitrosigine® Is Now Fueling Black Onyx Shatter Neuro N.O. From Muscletech™️
Nutrition 21, LLC (“Nutrition 21”), has announced that its clinically substantiated ingredient, Nitrosigine®, is now featured in Black Onyx…
August 23, 2018
Nitrosigine® Is Now Powering UP C4 Ultimate® Shred From Cellucor®
Nutrition 21, LLC (“Nutrition 21”), has announced that its clinically substantiated ingredient, Nitrosigine®, is now featured in…
August 17, 2018
Nutrition21, LLC Announces New Additions to Sales and Senior Leadership Teams
Nutrition 21, LLC (“Nutrition 21”) s proud to announce that William “Skip” Hammock has joined Nutrition 21 as Manager of Key Accounts and…
July 11, 2018
Nutrition21 Study Adds Evidence Supporting More Bioavailable Form Of Arginine
Results presented at Nutrition 2018 Conference, hosted by the American Society of Nutrition, shows that Inositol-stabilized arginine is…
July 10, 2018
Nutrition 21, LLC Presents New Study Linking Nitrosigine®’s Enhanced Absorption to the Inhibition of Arginase at the American Society for Nutrition’s 2018 Annual Meeting
Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of new clinical study results demonstrating that Nitrosigine®…
Nutrition21 Proudly Supports the Following Industry Associations

©2023 Nutrition21, LLC. All rights reserved.
Nitrosigine®, Velositol®, nooLVL®, Lustriva®, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,028,879; 9,119,835; 9,597,404; 9,675,702; 10,183,049; and 10,245,325.
November 28, 2011